Evaluating very high energy electron RBE from nanodosimetric pBR322 plasmid DNA damage.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 02 2021
08 02 2021
Historique:
received:
06
08
2020
accepted:
07
12
2020
entrez:
9
2
2021
pubmed:
10
2
2021
medline:
12
11
2021
Statut:
epublish
Résumé
This paper presents the first plasmid DNA irradiations carried out with Very High Energy Electrons (VHEE) over 100-200 MeV at the CLEAR user facility at CERN to determine the Relative Biological Effectiveness (RBE) of VHEE. DNA damage yields were measured in dry and aqueous environments to determine that ~ 99% of total DNA breaks were caused by indirect effects, consistent with other published measurements for protons and photons. Double-Strand Break (DSB) yield was used as the biological endpoint for RBE calculation, with values found to be consistent with established radiotherapy modalities. Similarities in physical damage between VHEE and conventional modalities gives confidence that biological effects of VHEE will also be similar-key for clinical implementation. Damage yields were used as a baseline for track structure simulations of VHEE plasmid irradiation using GEANT4-DNA. Current models for DSB yield have shown reasonable agreement with experimental values. The growing interest in FLASH radiotherapy motivated a study into DSB yield variation with dose rate following VHEE irradiation. No significant variations were observed between conventional and FLASH dose rate irradiations, indicating that no FLASH effect is seen under these conditions.
Identifiants
pubmed: 33558553
doi: 10.1038/s41598-021-82772-6
pii: 10.1038/s41598-021-82772-6
pmc: PMC7870938
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3341Références
Tumour Biol. 2010 Aug;31(4):363-72
pubmed: 20490962
Med Phys. 2015 May;42(5):2615-25
pubmed: 25979053
Sci Transl Med. 2014 Jul 16;6(245):245ra93
pubmed: 25031268
J Theor Biol. 1987 Jul 21;127(2):229-45
pubmed: 2826926
Int J Radiat Biol. 1989 Jul;56(1):1-19
pubmed: 2569005
Int J Radiat Biol. 1992 Mar;61(3):345-53
pubmed: 1347067
Appl Radiat Isot. 2018 Jun;136:1-9
pubmed: 29448059
Acta Oncol. 1996;35(7):849-56
pubmed: 9004762
Radiat Res. 2011 Jun;175(6):797-805
pubmed: 21466384
Cell Death Dis. 2010 Sep 09;1:e73
pubmed: 21364677
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Phys Med Biol. 2014 Nov 21;59(22):R419-72
pubmed: 25361443
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nature. 1967 Aug 19;215(5103):847-8
pubmed: 6049731
Radiat Environ Biophys. 2015 Aug;54(3):343-52
pubmed: 26007308
Med Phys. 2009 Feb;36(2):620-5
pubmed: 19292002
Radiat Res. 1991 Nov;128(2):192-6
pubmed: 1947015
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Phys Med Biol. 2010 May 21;55(10):R65-109
pubmed: 20427859
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):407-415
pubmed: 31010708
Sci Rep. 2019 Mar 14;9(1):4471
pubmed: 30872656
Int J Radiat Biol. 2000 Jul;76(7):881-90
pubmed: 10923612
Radiother Oncol. 2019 Oct;139:18-22
pubmed: 31303340
Int J Radiat Biol. 1999 Jan;75(1):83-90
pubmed: 9972794
Phys Med Biol. 2000 Jul;45(7):1781-805
pubmed: 10943919
Med Phys. 2019 Jan;46(1):405-413
pubmed: 30418675
Biotechnology. 1992;24:153-71
pubmed: 1422009
Radiother Oncol. 2017 Sep;124(3):365-369
pubmed: 28545957
Phys Med. 2017 Jan;33:207-215
pubmed: 28017738
Int J Radiat Biol. 2015 Aug;91(8):643-52
pubmed: 25968557
Clin Cancer Res. 2019 Jan 1;25(1):35-42
pubmed: 29875213
Radiat Oncol. 2017 Jan 19;12(1):24
pubmed: 28107823
Int J Radiat Biol. 2005 Jan;81(1):41-54
pubmed: 15962762
J Mol Biol. 1960 Dec;2:379-91
pubmed: 13748451
Radiother Oncol. 2019 Oct;139:28-33
pubmed: 31178058
Radiat Res Suppl. 1985;8:S103-11
pubmed: 3867077
Nanoscale. 2017 Nov 30;9(46):18413-18422
pubmed: 29148554
J Radiat Res. 2017 Nov 1;58(6):894-897
pubmed: 28992052